Bingrong Liu

ORCID: 0000-0002-3136-1808
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Growth Hormone and Insulin-like Growth Factors
  • Cancer, Hypoxia, and Metabolism
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Retinoids in leukemia and cellular processes
  • Drug Transport and Resistance Mechanisms
  • Mitochondrial Function and Pathology
  • Cancer-related Molecular Pathways
  • Ubiquitin and proteasome pathways
  • Cancer Research and Treatments
  • Genetic factors in colorectal cancer
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer, Lipids, and Metabolism
  • Endoplasmic Reticulum Stress and Disease
  • NF-κB Signaling Pathways
  • Autophagy in Disease and Therapy
  • Protease and Inhibitor Mechanisms
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Colorectal Cancer Treatments and Studies
  • Chronic Lymphocytic Leukemia Research
  • Metabolism, Diabetes, and Cancer
  • Peptidase Inhibition and Analysis
  • Hippo pathway signaling and YAP/TAZ
  • Paraoxonase enzyme and polymorphisms

First Affiliated Hospital of Zhengzhou University
2017-2020

Harbin Medical University
2012-2020

Second Affiliated Hospital of Harbin Medical University
2014-2020

University of California, Los Angeles
2000-2010

Mattel Children's Hospital
2006-2008

Rather than being a passive, haphazard process of wear and tear, lifespan can be modulated actively by components the insulin/insulin-like growth factor I (IGFI) pathway in laboratory animals. Complete or partial loss-of-function mutations genes encoding insulin/IGFI result extension life span yeasts, worms, flies, mice. This remarkable conservation throughout evolution suggests that altered signaling this may also influence human lifespan. On other hand, evolutionary tradeoffs predict...

10.1073/pnas.0705467105 article EN Proceedings of the National Academy of Sciences 2008-03-04

Insulin-like growth factor-binding protein (IGFBP)-3 regulates apoptosis in an IGF-independent fashion and has been shown to localize nuclei. We cloned the nuclear receptor retinoid X receptor-alpha(RXR-alpha) as IGFBP-3 partner a yeast two-hybrid screen. Multiple methodologies showed that RXR-alpha bind each other within nucleus. IGFBP-3-induced was abolished RXR-alpha-knockout cells. RXR ligands were additive inducing prostate cancer enhanced response element inhibited RARE signaling....

10.1074/jbc.m002547200 article EN cc-by Journal of Biological Chemistry 2000-10-01

Abstract Background & Aims Mitochondrial dynamics of fission and fusion plays critical roles in a diverse range important cellular functions, its deregulation has been increasingly implicated human diseases. Previous studies have shown that increased mitochondrial significantly promoted the proliferation hepatocellular carcinoma (HCC) cells. However, how they influence migration tumour cells remained largely unknown. Methods In present study, we further investigated effect on metastasis...

10.1111/liv.13660 article EN Liver International 2017-12-06

BACKGROUND:Accumulating evidence suggests the involvement of long non-coding RNAs (lncRNAs) as oncogenic or tumor suppressive regulators in development various cancers. In present study, we aimed to identify a lncRNA signature based on RNA sequencing (RNA-seq) data predict survival esophageal cancer. MATERIAL AND METHODS:The RNA-seq expression and clinical information were downloaded from The Cancer Genome Atlas (TCGA) database. Differentially expressed lncRNAs screened out between cancer...

10.12659/msm.902615 article EN Medical Science Monitor 2016-12-28

Colorectal cancer (CRC) is one of the most leading causes deaths worldwide. In study, we aimed to identify key long non-coding RNAs (lncRNAs) significantly associated with prognosis CRC and develop an expression-based lncRNA signature provide survival risk prediction for patients. LncRNA expression profiles clinical information patients were collected from The Cancer Genome Atlas (TCGA) database. Six hundred eighteen differentially expressed lncRNAs identified between normal tissues. After...

10.1002/jcb.26548 article EN Journal of Cellular Biochemistry 2017-12-11

Mesenchymal stem cell (MSC) transplantation has emerged as an option for the treatment of chronic hepatic cirrhosis, while its therapeutic efficacy could be improved. The bcl-2 gene is anti-apoptotic and can help survival proliferation. Therefore, we explored whether transplanted MSCs with enhanced expression may beneficial in experimental cirrhosis rats.MSCs were isolated from rat bone marrow, expanded vitro transfected adeno-associated virus (AAV) engineered (AAV-bcl-2). Rats induced by...

10.1159/000453166 article EN cc-by-nc-nd Cellular Physiology and Biochemistry 2016-01-01

This study was aimed to develop a lncRNA-associated competing endogenous RNA (ceRNA) network provide further understanding of the ceRNA regulatory mechanism and pathogenesis in colorectal cancer (CRC).Expression profiles mRNAs, lncRNAs, miRNAs, clinical information for CRC patients were obtained from The Cancer Genome Atlas. differentially expressed miRNAs (referred as "DEmRNAs", "DElncRNAs", "DEmiRNAs", respectively) screened out between 539 samples 11 normal samples. interactions DElncRNAs...

10.2147/ott.s158309 article EN cc-by-nc OncoTargets and Therapy 2018-04-30

The epithelial-mesenchymal transition (EMT) is a pivotal process for fibrotic disease, embryonic development, and wound healing. Moreover, some evidence has proven that the disorder of EMT also plays an important role in carcinogenesis, especially invasion metastasis various tumors (Ritchie et al., 2015). Additionally, gastric adenocarcinoma (GAC) common gastrointestinal malignancy which fourth most commonly diagnosed tumor. Our study aimed at identifying prognostic value EMT-related genes...

10.1155/2020/7082408 article EN cc-by BioMed Research International 2020-03-20

Abstract Insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) promotes apoptosis of cancer cells by both IGF-dependent and IGF-independent mechanisms. In vitro phosphorylation IGFBP-3 DNA-dependent protein kinase (DNA-PK) has been reported but with unknown functional relevance. Using a chemical inhibitor for DNA-PK in prostate paired system glioblastoma cell lines that either lack or express DNA-PK, we show the apoptosis-promoting growth-inhibitory actions are completely abrogated...

10.1158/0008-5472.can-06-0585 article EN Cancer Research 2006-11-15

The Journal of Cancer Metastasis and Treatment is an open access journal focused on cancer metastasis treatment, including the occurrence, development, progression, metastasis, treatment oncologic disease. It covers basic, translational clinical research related to cell biology, genomics, precision medicine, oncology internal radiotherapy radiology, obstetrics gynecology, pediatrics, surgery, hematology, neurooncology, etc.

10.20517/2394-4722.2016.62 article EN Journal of Cancer Metastasis and Treatment 2016-12-29

This study aimed to investigate the impact of combined use nuclear factor-κB (NF-κB) inhibitors pyrrolidine dithiocarbamate (PDTC), bortezomib or SN50, and chemotherapy agents arsenic acid (As(2)O(3)), fluorouracil (5FU), oxaliplatin paclitaxel on growth apoptosis HT-29 cells. Cell morphology was observed using inverted microscopy, cell viability were assessed MTT assay flow cytometry, respectively. The activities NF-κB analyzed by western blotting electrophoretic mobility shift (EMSA)....

10.3892/etm.2012.647 article EN Experimental and Therapeutic Medicine 2012-07-24

NPRL2 is a tumor suppressor gene involved in the progression of human cancer. The present study investigated whether expression correlates with colorectal cancer (CRC) progression. Colorectal tissue and peripheral blood samples were obtained from 62 patients CRC, 38 adenomas 51 normal controls. mRNA levels measured using quantitative real-time PCR. protein was determined by immunohistochemistry. CRCs significantly lower than or tissue. decreased compared controls (P<0.0001) it further tumors...

10.4161/cbt.28016 article EN Cancer Biology & Therapy 2014-02-12

Bortezomib, a first‑in‑class proteasome inhibitor, is standard method of treatment in multiple myeloma. In the present study, therapeutic effect bortezomib was evaluated an ulcerative colitis model induced by dextran sulfate sodium (DSS) mice, and mechanism action also investigated. Mice were administered with 3% DSS drinking water for 7 consecutive days then they intraperitoneally treated (0.2, 0.6 or 1 mg/kg) 1, 3 days. control group provided same volume PBS, respectively. Body weight,...

10.3892/mmr.2017.6524 article EN cc-by-nc-nd Molecular Medicine Reports 2017-04-27

Accumulating evidence suggested that long non-coding RNAs (lncRNAs) can function as competing endogenous (ceRNAs) to interact with other RNA transcripts and ceRNAs perturbation play important roles in cancer initiation progression including pancreatic adenocarcinoma (PAAD). In this study, we constructed a PAAD-specific hallmark gene-related ceRNA network (HceNet) using paired genome-wide expression profiles of mRNA, lncRNA miRNA regulatory relationships between them. Based on "ceRNA...

10.18632/oncotarget.21783 article EN Oncotarget 2017-10-10

Purpose: The study aimed to explore the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer (CRC) using combined method microarray and bioinformatics analysis. Materials methods: Cell proliferation was tested by Counting Kit-8 (CCK-8) assay for SW620 cells treated with different concentrations ixazomib treatment times. analysis conducted six samples, including three samples untreated ixazomib. differentially expressed genes (DEGs) between were identified Linear...

10.2147/ott.s139686 article EN OncoTargets and Therapy 2017-07-01

5-Fluorouracil (5-FU) is the chemotherapeutic drug of choice for treatment metastatic colorectal cancer (CRC). Tumor suppressor candidate 4 (TUSC4), also referred to as nitrogen permease regulator-like 2 (NPRL2), located at chromosome 3p21.3 and expressed in numerous normal tissues, including heart, liver, skeletal muscle, kidney, pancreas. The aim present study was investigate functional mechanism by which TUSC4 affects sensitivity 5-FU determine its clinical significance CRC. results...

10.3892/ol.2015.3801 article EN Oncology Letters 2015-10-13

Colon cancer remains a life-threating disease with increasing morbidity and mortality worldwide despite the advancement in modern medical treatment. Therefore, novel effective anti-colon cancers drugs are urgently needed. In this study, we investigated anti-metastatic property EnDuo, modified version of Endostar, underlying mechanisms. cells were treated different concentrations EnDuo (50 μg/mL, 100 200 μg/mL), Endostar (100 μg/mL) as positive control. Cell Counting Kit-8 assay was performed...

10.1016/j.biopha.2020.111136 article EN Biomedicine & Pharmacotherapy 2020-12-17

The nitrogen permease regulator‑like‑2 (NPRL2) gene is a candidate tumor suppressor gene, which has been identified in the 3p21.3 human chromosome region. Decreased expression levels of NPRL2 have observed colorectal cancer (CRC) tissues, however, function CRC progression remains to be fully elucidated. present study investigated biological characteristics HCT116 and HT29 cell lines overexpressing exogenous NPRL2. recombinant lentiviral vectors were also constructed transfected study. Cell...

10.3892/mmr.2015.3881 article EN cc-by-nc Molecular Medicine Reports 2015-06-03

Previous studies have suggested that hepatocyte apoptosis may be a fundamental underlying mechanism of liver injury and diseases, such as fibrosis. Relaxin‑3 has been reported to anti‑fibrotic actions in the heart attenuate isoproterenol‑induced myocardial injury; however, beneficial role relaxin‑3 on remains elucidated. The aim present study was explore possible mechanisms through hydrogen peroxide (H2O2)‑induced primary human hepatocytes. Cells were treated with then cell viability,...

10.3892/mmr.2014.2842 article EN Molecular Medicine Reports 2014-11-03

Colorectal cancer (CRC) is the third most common worldwide. Chemotherapeutic compounds used for treatment of CRC include oxaliplatin (L-OHP). While L-OHP improves survival, certain patients are resistant. The nitrogen permease regulator like-2 (NPRL2) gene a candidate tumor suppressor that resides in 120-kb homozygous deletion region on chromosome 3p21.3. In present study, it was demonstrated NPRL2 overexpression increases sensitivity HCT116 cells to L-OHP. IC50 decreased transduced with...

10.3892/mmr.2015.3495 article EN Molecular Medicine Reports 2012-03-13

BACKGROUND Colorectal cancer (CRC) is the third most common worldwide, making it a serious threat to human health. It imperative develop new therapeutics improve CRC treatment efficiency. The aim of this study was investigate role NPRL2 in improving sensitivity CPT-11 colon cells. MATERIAL AND METHODS overexpression established by transfecting recombinant lentivirus-encoding gene into HCT116 Cell proliferation identified using Counting Kit-8 (CCK8) assay. cycle and apoptosis were examined...

10.12659/msm.909186 article EN Medical Science Monitor 2018-03-09
Coming Soon ...